AI assistant
DEXCOM INC — Director's Dealing 2015
Sep 11, 2015
30198_dirs_2015-09-11_45e89dd4-0639-4c23-8f44-27437976ea4d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-09-09
Reporting Person: MOY JEFFREY (SVP, Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-09 | Common Stock | J | 8333.0 | $91.05 | Disposed | 81667 | Direct |
| 2015-09-09 | Common Stock | J | 8333.0 | $91.05 | Acquired | 60469 | Indirect |
| 2015-09-09 | Common Stock | D | 4404.0 | $90.8985 | Disposed | 56065 | Indirect |
Footnotes
F1: Shares were transferred from direct ownership to ownership under the Moy Family Trust upon vesting of previously awarded restricted stock units.
F2: Included in this number are 73,334 unvested restricted stock units, 40,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 25,000 of which were granted on March 8, 2014 and shall vest through March 08, 2017, and 8,334 of which were granted on March 11, 2013 and shall vest through March 11, 2016.
F3: Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee.
F4: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.